Interferon β-1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase-9

Annals of Neurology

Volumn 40, Issue 6, 1996, Pages 853-863

  Stüve, Olaf ^a   Dooley, Nora P ^a   Uhm, Joon H ^a   Antel, Jack P ^a   Francis, Gordon S ^a   Williams, Gary ^b   Yong, Voon Wee ^a,c  

^a MCGILL UNIVERSITY   (Canada)

^b BAYER AG   (Germany)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; GAMMA INTERFERON; GELATINASE B; INTERFERON BETA SERINE; INTERLEUKIN 2; MATRIX METALLOPROTEINASE INHIBITOR; OKT 3; PHENANTHROLINE DERIVATIVE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; BASEMENT MEMBRANE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE MIGRATION; LYMPHOCYTIC INFILTRATION; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ADJUVANTS, IMMUNOLOGIC; CELL MOVEMENT; COLLAGENASES; HUMANS; INTERFERON-BETA; KILLER CELLS, NATURAL; MATRIX METALLOPROTEINASE 9; T-LYMPHOCYTES;

EID: 0030498666     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410400607     Document Type: Article

References (53)

1. Hohlfeld R, Meinl E, Weber F, et al. The role of autoimmune T lymphocytes in the pathogenesis of multiple sclerosis. Neurology 1995;45:S33-S38
2. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76: 301-314
3. Bevilacqua MP. Endothelial-leukocyte adhesion molecules. Annu Rev Immunol 1993;11:767-804
4. Bevilacqua MP, Nelson RM. Selectins. J Clin Invest 1993;91: 379-387
5. Cross AH, O'Mara T, Raine CS. Chronologic localization of myelin-reactive cells in the lesions of relapsing EAE: implications for the study of multiple sclerosis. Neurology 1993;43: 1028-1033
6. The IFNβ Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993;43:655-661
7. Paty DW, Li DK. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group. Neurology 1993;43:662-667
8. The IFNβ Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group. Interteron beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 1995;45:1277-1285
9. Jacobs LD, Cookfair DL, Rudick RA, et al. Intramuscular interferon beta-1-alpha for disease progression in relapsing multiple sclerosis. Ann Neurol 1996;39:285-294
10. Fernández O, Antiquëdad A, Arbizu T, et al. Treatment of relapsing-remitting multiple sclerosis with natural interferon beta: a multicenter, randomized clinical trial. Multiple Sclerosis 1995;1:S67-S69
11. Abreu SL. Suppression of experimental allergic encephalomyelitis by interferon. Immunol Commun 1982;11:1-7
12. Abreu SL. Interferon in experimental autoimmune encephalomyelitis (EAE): effects of exogenous interferon on the antigen-enhanced adoptive transfer of EAE. Int Arch Allergy Appl Immunol 1985;76:302-307
13. Yu M, Nishiyama A, Trapp BD, Tuohy VK. Interferon-beta inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis. J Neuroimmunol 1996;64; 91-100
14. Noronha A, Toscas A, Jensen MA. Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis. J Neuroimmunol 1993;46:145-153
15. Noronha A, Toscas A, Jensen MA. Interferon beta augments suppressor cell function in multiple sclerosis. Ann Neurol 1990;27:207-210
16. Matrisian LM. The matrix-degrading metalloproteinases. Bioessays 1992;14:455-463
17. Woessner JF Jr. The family of matrix metalloproteinases. Ann NY Acad Sci 1994;732:11-21
18. Gohji K, Fidler IJ, Tsan R, et al. Human recombinant interferons-beta and -gamma decrease gelatinase production and invasion by human KG-2 renal-carcinoma cells. Int J Cancer 1994; 58:380-384
19. Kato N, Nawa A, Tamakoshi K, et al. Suppression of gelatinase production with decreased invasiveness of choriocarcinoma cells by human recombinant interferon beta. Am J Obstet Gynecol 1995;172:601-606
20. Yong VW, Moumdjian R, Yong FP, et al. Gamma-interferon promotes proliferation of adult human astrocytes in vitro and reactive gliosis in the adult mouse brain in vivo. Proc Natl Acad Sci USA 1991;88:7016-7020
21. Albini A, Iwamoto Y, Kleinman HK, et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987;47:3329-3345
22. Overall CM, Wrana JL, Sodek J. Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. J Biol Chem 1989;264:1860-1869
23. Ramos-De Simone N, French DL. Monoclonal antibodies to human MMP-9. Ann NY Acad Sci 1994;732:469-471
24. Zhou H, Bernhard EJ, Fox FE, Billings PC. Induction of metalloproteinase activity in human T-lymphocytes. Biochim Biophys Acta 1993;1177:174-178
25. Miltenburg AM, Lacraz S, Welgus HG, Dayer JM. Immobilized anti-CD3 antibody activates T cell clones to induce the production of interstitial collagenase, but not tissue inhibitor of metalloproteinases, in monocytic THP-1 cells and dermal fibroblasts. J Immunol 1995;154:2655-2667
26. Paganetti PA, Caroni P, Schwab ME. Glioblastoma infiltration into central nervous system tissue in vitro: involvement of a metalloprotease. J Cell Biol 1988;107:2281-2291
27. Goldberg GI, Strongin A, Collier IE, et al. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metallo-proteinase prevents dimerization, complex formation with interstitial collagenase and activation of the proenzyme with stromelysin. J Biol Chem 1992;267:4583-4591
28. Esiri MM, Morris CS. Immunocytochemical study of macrophages and microglial cells and extracellular matrix components in human CNS disease. 2. Non-neoplastic diseases. J Neurol Sci 1991;101:59-72
29. Sobel RA, Mitchell ME. Fibronectin in multiple sclerosis lesions. Am J Pathol 1989;135:161-168
30. Oh LYS, Yong VW. Astrocytes promote process outgrowth by adult human oligodendrocytes in vitro through interaction between bFGF and astrocyte extracellular matrix. Glia 1996;17: 237-253
31. Pasinetti GM, Nichols NR, Tocco G, et al. Transforming growth factor beta 1 and fibronectin messenger RNA in rat brain: responses to injury and cell-type localization. Neuroscience 1993;54:893-907
32. Ostergaard HL, Ma EA. Fibronectin induces phosphorylation of a 120-kDa protein and synergizes with the T cell receptor to activate cytotoxic T cell. Eur J Immunol 1995;25:252-256
33. Davis JM, St John J, Cheung HT. Haptotactic activity of fibronectin on lymphocyte migration in vitro. Cell Immunol 1990;129:67-79
34. Hauzenberger D, Klominek J, Sundqvist KG. Functional specialization of fibronectin-binding beta 1-integrins in T lymphocyte migration. J Immunol 1994;153:960-971
35. Elices MJ, Tsai V, Strahl D, et al. Expression and functional significance of alternatively spliced CS1 fibronectin in rheumatoid arthritis microvasculature. J Clin Invest 1994;93:405-416
36. Larjava H, Lyons JG, Salo T, et al. Anti-integrin antibodies induce type IV collagenase expression in keratinocytes. J Cell Physiol 1993;157:190-200
37. Khan OA, Xia Q, Bever CT, et al. Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration. Neurology 1996;46:1639-1643
38. Leppert D, Waubant E, Galardy R, et al. T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 1995;154:4379-4389
39. Xia M, Leppert D, Hauser SL, et al. Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. J Immunol 1996; 156:160-167
40. Fabry Z, Topham DJ, Fee D, et al. TGF-beta 2 decreases migration of lymphocytes in vitro and homing of cells into the central nervous system in vivo. J Immunol 1995;155:325-332
41. Cross AH, Cannella B, Brosnan CF, Raine CS. Homing to central nervous system vasculature by antigen-specific lymphocytes. I. Localization of 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis. Lab Invest 1990;63:162-170
42. Sedgwick J, Brostoff S, Mason D. Experimental allergic encephalomyelitis in the absence of a classical delayed-rype hypersensitivity reaction. Severe paralytic disease correlates with the presence of interleukin 2 receptor-positive cells infiltrating the central nervous system. J Exp Med 1987;165:1058-1075
43. Gijbels K, Galardy RE, Steinman L. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J Clin Invest 1994;94:2177-2182
44. Hewson AK, Smith T, Leonard JP, Cuzner ML. Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro 31-9790. Inflam Res 1995;44:345-349
45. Pollard JD, Westland KW, Harvey GK, et al. Activated T cells of nonneural specificity open the blood-nerve barrier to circulating antibody. Ann Neurol 1995;37:467-475
46. Stone LA, Frank JA, Albert PS, et al. The effect of interferon-β on blood-brain barrier disruptions demonstrated by contrastenhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis. Ann Neurol 1995;37:611-619
47. Yednock TA, Cannon C, Fritz LC, et al. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 1992;356:63-66
48. Kent SJ, Karlik SJ, Cannon C, et al. A monoclonal antibody to alpha 4 integrin suppresses and reverses active experimental allergic encephalomyelitis. J Neuroimmunol 1995;58:1-10
49. Kuchroo VK, Martin CA, Greer JM, et al. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J Immunol 1993;151:4371-4382
50. Tanaka M, Sato A, Makino M, Tabira T. Binding of an SJL T cell clone specific for myelin basic protein to SJL brain microvessel endothelial cells is inhibited by anti-VLA-4 or its ligand, anti-vascular cell adhesion molecule 1 antibody. J Neuroimmunol 1993;46:253-257
51. Baron JL, Madri JA, Ruddle NH, et al. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med 1993;177:57-68
52. Gearing AJ, Beckett P, Christodoulou M, et al. Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 1994;370:555-557
53. McGeehan GM, Becherer JD, Bast RC Jr, et al. Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor. Nature 1994;370:558-561